LOS ANGELES, US/DUBAI, UAE: The UAE Ministry of Health and Prevention has authorised the use of Second Opinion, an artificial intelligence (AI) tool that assists in dental radiology. Produced by the company Pearl, the device is designed to help dental professionals scan and detect a wide range of dental conditions using radiographs.
Second Opinion applies computer vision technologies to detect a comprehensive array of pathologies, existing restorations and natural anatomy in dental radiographs. According to the company, the system analyses radiographs in real time, allowing dentists to display, review, add or reject the system’s detections while conducting examinations.
“With Second Opinion cleared, patients in the UAE can begin to gain the many benefits of AI-assisted dentistry and greater assurance in quality of care at Second Opinion-equipped dental practices,” said Dr Oussama Alaoui, head of prosthodontics at Harmony Medical Center in Abu Dhabi, in a press release. He added: “I look forward to witnessing the revolutionary impact and advantages that AI will bring to our dental care.”
Ophir Tanz, CEO and founder of Pearl, commented on the market launch: “Our Second Opinion technology enables more efficient and transparent doctor–patient communication while facilitating a higher standard of care. With the implementation of the platform in the UAE, we are excited to take a first step towards driving growth and better patient outcomes across Middle Eastern dentistry.”
In an interview, Tanz said that Second Opinion improves doctor–patient communication as dentists can clearly communicate their diagnosis with the support of the tool, giving their patients a greater sense of assurance. “It eliminates the doubt that makes patients seek a second opinion elsewhere—that is why we call it Second Opinion,” he explained.
The latest clearance follows the solution’s CE-marking in Europe, its Medical Device Establishment License for use in Canada, its clearance from the Therapeutic Goods Administration in Australia and, in New Zealand, its clearance from the New Zealand Medicines and Medical Devices Safety Authority.
More information on Second Opinion can be found at www.hellopearl.com/products/second-opinion.
Tags:
BOSTON, US: Overjet, a dental start-up that develops software powered by artificial intelligence (AI), recently announced that it has received 510(k) ...
HOUSTON, Texas, USA: OrthoAccel Technologies, a manufacturer of accelerated orthodontics technology, has received FDA clearance for its newest accelerated ...
NEW YORK/LEIPZIG, Germany: The US Food and Drug Administration have has given clearance for Genesis, a new implant system developed by Keystone Dental in ...
FOOTHILL RANCH, Calif., USA: BIOLASE and EdgeEndo have announced the FDA 510(k) clearance of the EdgePRO system for endodontists seeking a more effective ...
Sonendo announced recently that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the next generation of its GentleWave ...
LOS ANGELES, CA, USA: The Shapiro Family Charitable Foundation in the US has made a US$1 million pledge to the University of California, Los Angeles (UCLA) ...
MIAMI, Fla., USA: Neocis, a supplier of robot-assisted dental implant surgery, has announced it has received 510(k) clearance from the U.S. Food and Drug ...
LANSDALE, Pa., USA: X-Nav Technologies — a medical device company that develops surgical products intended to advance patient care while improving doctor ...
MELVILLE, N.Y., USA: Henry Schein Inc. announced today that Steven W. Kess, vice president, global professional relations, and president of the Henry Schein...
BUFFALO, N.Y., USA: Robert J. Genco, DDS, PhD, SUNY Distinguished Professor, director of the University at Buffalo Science, Technology Transfer and Economic...
Live webinar
Thu. 18 July 2024
8:00 PM EST (New York)
Live webinar
Tue. 6 August 2024
6:00 PM EST (New York)
Live webinar
Tue. 13 August 2024
7:00 PM EST (New York)
Live webinar
Wed. 21 August 2024
9:00 AM EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 PM EST (New York)
Live webinar
Mon. 2 September 2024
5:00 AM EST (New York)
Live webinar
Tue. 3 September 2024
11:00 AM EST (New York)
To post a reply please login or register